Workflow
Artificial Intelligence in Biopharma
icon
Search documents
Recursion(RXRX) - 2025 Q2 - Earnings Call Transcript
2025-08-05 13:02
Recursion Pharmaceuticals (RXRX) Q2 2025 Earnings Call August 05, 2025 08:00 AM ET Company ParticipantsChris Gibson - Co-Founder, CEO & Board MemberNajat Khan - Chief R&D Officer, Chief Commercial Officer and DirectorBen Taylor - CFO & President - Recursion UKChris GibsonRecursion's q two twenty twenty five earnings call. My name is Chris Gibson, and I'm the cofounder and CEO of Recursion. And I'm excited to share with you today some of the latest updates on our company as we drive forward to decode biology ...